December 2, 2023 Comments Off on New patent for Glaxosmithkline drug ANORO ELLIPTA Posted in: Patent Added Annual Drug Patent Expirations for ANORO+ELLIPTA Anoro Ellipta is a drug marketed by Glaxosmithkline and is included in one NDA. It is available from one supplier. There are fourteen patents…
The post New patent for Glaxosmithkline drug ANORO ELLIPTA a…
December 2, 2023 Comments Off on New patent for Glaxosmithkline drug TRELEGY ELLIPTA Posted in: Patent Added Annual Drug Patent Expirations for TRELEGY+ELLIPTA Trelegy Ellipta is a drug marketed by Glaxosmithkline and is included in one NDA. It is available from one supplier. There are fourteen patents…
The post New patent for Glaxosmithkline drug TRELEGY ELL…